Maintaining adolescent confidentiality in care
An adolescent patient's right to privacy is crucial, especially for ob/gyns.
A presentation at the virtual 2020 American Academy of Pediatrics National Conference and Exhibition showed how two health care systems walk the line to protect their adolescent patients’ right to privacy.
Especially for ob/gyns, maintaining patient privacy is crucial. Adolescent patients may be concerned about this, especially if the nature of the visit is especially personal. Will their parents find out about their STD test results?
During the presentation “Mum’s the word: Adolescent consent to care and confidentiality (and EHRs)” at the virtual 2020 American Academy of Pediatrics National Conference & Exhibition, Ryan H. Pasternak, MD, MPH, FAAP, professor of clinical pediatrics at the Louisiana State University School of Medicine in New Orleans, and Kirsten B. Hawkins, MD, MPH, FAAP, FSAHM, discussed how the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule affects adolescent confidentiality, the 21st Century CURES act and electronic health records, and how their health systems protected adolescent confidentiality.
For further details, visit Contemporary Pediatrics.
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More
PCOS and irregular cycles tied to cardiometabolic risks
May 15th 2024A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.
Read More
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More